News and Announcements
GlaxoSmithKline Extends Service Agreement with MedAdvisor
- Published June 16, 2016 2:19PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
16th June 2016, ASX Announcement
Highlights
- GlaxoSmithKline (GSK) Australia extends its services agreement with MedAdvisor for a further 12 months.
- GSK will continue utilising MedAdvisor’s medication management platform to provide relevant information for patients prescribed three medicines within GSK Australia’s respiratory portfolio.
- Agreement will generate Patient Engagement Program (PEP), formerly knows as Medication Training and Adherence Campaigns (MTAC), revenue for MedAdvisor.
- Allows GKS Australia to leverage the MedAdvisor platform to support patients on the safe and effective use of these medicines.
MedAdvisor Limited (ASX: MDR, the Company), Australia’s leading digital medication adherence company, is pleased to announce that the Australian arm of leading global pharmaceutical company, GlaxoSmithKline Australia Pty (GSK) has extended its services agreement with MedAdvisor for a further 12 months.
Under the agreement, GSK Australia will continue providing tailored messages to patients prescribed medicines with GSK Australia’s respiratory portfolio.
To view the full announcement, please click on the button below.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
